Department of Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS, United States.
Department of Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS, United States.
Mult Scler Relat Disord. 2020 May;40:101958. doi: 10.1016/j.msard.2020.101958. Epub 2020 Jan 23.
At least 40% of individuals with multiple sclerosis (MS) exercise chronic insomnia, and the prevalence is likely higher due to underdiagnosis. Poor sleep quality has been associated with increased fatigue, anxiety, depression, and risk of relapse in individuals with MS. While cognitive behavioral therapy for insomnia (CBT-I) is the recommended treatment for chronic insomnia, the treatment effect of CBT-I in people with MS is unclear.
This pilot randomized control trial (RCT) assessed the feasibility and treatment effect of CBT-I to improve sleep quality and fatigue in individuals with MS with symptoms of insomnia.
Thirty-three individuals with MS (30 females, 3 males; 30 relapsing-remitting; 3 secondary-progressive; 53.0 ± 9.4 years old) with symptoms of insomnia were randomized into one of three arms: 1. 6-week CBT-I program, 2. 6-week active control, or 3. Single session of sleep education. Participants completed surveys to assess sleep quality, fatigue, sleep self-efficacy, depression, and anxiety.
CBT-I in individuals with MS is feasible with high retention and adherence rate. All groups experienced a large magnitude of improvement in insomnia symptoms. The CBT-I and brief education groups experienced a large magnitude of improvement in sleep quality and fatigue. Only the CBT-I group demonstrated a large magnitude of improvement in sleep self-efficacy and depression.
This is the first study to prospectively demonstrates that CBT-I is feasible in people with MS and produces promising improvements in insomnia severity, sleep quality, sleep self-efficacy and comorbid symptoms of fatigue, depression, and anxiety. Future studies are needed to determine mechanisms for these improvements and expand the scope of individuals with MS who may benefit from CBT-I. Furthermore, considering the moderate to large improvements experienced by the brief education group and the limited number of CBT-I providers, a stepped-care approach warrants consideration.
至少有 40%的多发性硬化症(MS)患者患有慢性失眠症,由于诊断不足,患病率可能更高。睡眠质量差与 MS 患者的疲劳、焦虑、抑郁和复发风险增加有关。认知行为疗法治疗失眠症(CBT-I)是治疗慢性失眠症的推荐方法,但 CBT-I 对 MS 患者的治疗效果尚不清楚。
这项试点随机对照试验(RCT)评估了 CBT-I 改善有失眠症状的 MS 患者睡眠质量和疲劳的可行性和治疗效果。
33 名有失眠症状的 MS 患者(30 名女性,3 名男性;30 名复发缓解型;3 名继发进展型;53.0±9.4 岁)被随机分为三组之一:1.6 周 CBT-I 方案,2.6 周活性对照,或 3.单次睡眠教育。参与者完成了调查,以评估睡眠质量、疲劳、睡眠自我效能、抑郁和焦虑。
CBT-I 在 MS 患者中是可行的,具有高保留率和高依从率。所有组在失眠症状方面都有很大程度的改善。CBT-I 和简短教育组在睡眠质量和疲劳方面都有很大程度的改善。只有 CBT-I 组在睡眠自我效能和抑郁方面有很大程度的改善。
这是第一项前瞻性研究表明,CBT-I 在 MS 患者中是可行的,并在失眠严重程度、睡眠质量、睡眠自我效能以及疲劳、抑郁和焦虑的共病症状方面产生了有希望的改善。需要进一步的研究来确定这些改善的机制,并扩大可能从 CBT-I 中受益的 MS 患者的范围。此外,考虑到简短教育组和 CBT-I 提供者数量有限,中等至大的改善,分层护理方法值得考虑。